Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity

Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis

(2021) Sascha D. Markowitsch et al.   Cancers

Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles

(2021) Xinglong Fan et al.   BIOMEDICINE & PHARMACOTHERAPY

Combination Therapy of Metastatic Castration-Recurrent Prostate Cancer: Hyaluronic Acid Decorated, Cabazitaxel-Prodrug and Orlistat Co-Loaded Nano-System

(2021) Zhen Qu et al.   Drug Design Development and Therapy

Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles

(2020) Junjian Wang   Drug Design Development and Therapy

Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines

(2020) Ge Chen et al.   BIOMEDICINE & PHARMACOTHERAPY

Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine

(2020) Yuan Hong et al.   Drug Design Development and Therapy

Curcumin Nanoparticles and Their Cytotoxicity in Docetaxel-Resistant Castration-Resistant Prostate Cancer Cells

(2020) Irin Tanaudommongkon et al.   Biomedicines

Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform

(2020) Zhen Liang et al.   Drug Design Development and Therapy

Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates

(2020) Mahmood Barani et al.   Nanomaterials

Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine

(2019) Yuan Hong et al.   BIOMEDICINE & PHARMACOTHERAPY

Focus on Formononetin: Anticancer Potential and Molecular Targets

(2019) Ong et al.   Cancers

Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer

(2019) Wei Fu et al.   BIOMEDICINE & PHARMACOTHERAPY

Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system

(2019) Jing Guo et al.   BIOMEDICINE & PHARMACOTHERAPY

Management of Advanced and Metastatic Prostate Cancer: A Need for a Sub-Saharan Guideline

(2019) Ayun Cassell et al.   Journal of Oncology

Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft

(2018) Joshua J. Souchek et al.   Acta Biomaterialia

Transferrin and tocopheryl-polyethylene glycol-succinate dual ligands decorated, cisplatin loaded nano-sized system for the treatment of lung cancer

(2018) Guobin Xu et al.   BIOMEDICINE & PHARMACOTHERAPY

Endothelial growth factor receptor-targeted and reactive oxygen species-responsive lung cancer therapy by docetaxel and resveratrol encapsulated lipid-polymer hybrid nanoparticles

(2018) Zizheng Song et al.   BIOMEDICINE & PHARMACOTHERAPY

Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways

(2018) Ai‑Lei Wang et al.   Molecular Medicine Reports

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment

(2017) Tongxing Cui et al.   ONCOLOGY REPORTS

Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer

(2017) Rongrong Zhang et al.   Drug Design Development and Therapy

Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo

(2017) Sheng Tan et al.   Drug Design Development and Therapy

RGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma

(2016) Can Wang et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activityin vitroandin vivo

(2015) Jieke Yan et al.   DRUG DELIVERY

Multifunctional Nanoparticles for Prostate Cancer Therapy

(2014) Shantanu S. Chandratre et al.   AAPS PHARMSCITECH

Up-regulating of RASD1 and Apoptosis of DU-145 Human Prostate Cancer Cells Induced by Formononetin in Vitro

(2014) Xiao-Jia Liu et al.   Asian Pacific Journal of Cancer Prevention

Formononetin Promotes Cell Cycle Arrest via Downregulation of Akt/Cyclin D1/CDK4 in Human Prostate Cancer Cells

(2014) Tianyu Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles

(2013) Chunxi Liu et al.   BIOMATERIALS

Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway

(2013) Wen-Jun Huang et al.   PHARMACEUTICAL BIOLOGY

Formononetin-induced Apoptosis of Human Prostate Cancer Cells Through ERK1/2 Mitogen-activated Protein Kinase Inactivation

(2012) Y. Ye et al.   HORMONE AND METABOLIC RESEARCH

Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel

(2011) Hyun-Jong Cho et al.   BIOMATERIALS

TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer

(2011) Stephane Oudard   Future Oncology

Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): Preparation, pharmacokinetics, tissue distribution and antitumor activity

(2011) Lili Wang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

(2009) A. Horwich et al.   ANNALS OF ONCOLOGY

Quantitative determination of formononetin and its metabolite in rat plasma after intravenous bolus administration by HPLC coupled with tandem mass spectrometry

(2009) Sheelendra Pratap Singh et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery

(2009) Wangyang Yu et al.   NANOTECHNOLOGY

Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer

(2008) Weiwei Zou et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study

(2008) Dominik R. Berthold et al.   JOURNAL OF CLINICAL ONCOLOGY